Login to Your Account



In for a Penny, in for a Pound

Amgen Makes $1.16B Bid for BiTE Antibody Firm Micromet

By Catherine Shaffer
BioWorld Today Contributing Writer

Friday, January 27, 2012

Perhaps the ultimate sign of a satisfied customer is a willingness to pay more than $1 billion for a company after using a product for six months. Having had a taste of Micromet Inc.'s BiTE antibody platform through a license agreement inked July 12, 2011, Amgen Inc., of Thousand Oaks, Calif., offered $1.16 billion to acquire the Rockville, Md.-based company.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription